Bispecific antibodies and antibody-drug conjugates and uses thereof
TW202629608APending Publication Date: 2026-07-16PHRONTLINE BIOPHARMA (HANGZHOU) CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114139546
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-09-25
- Filing Date
- 2025-10-14
- Publication Date
- 2026-07-16
Abstract
The present disclosure relates to bispecific antibodies targeting B7-H3 and EGFR, and antibody-drug conjugates (ADCs) based on the bispecific antibodies, and compositions comprising the bispecific antibodies and ADCs and their medical uses.
Need to check novelty before this filing date? Find Prior Art